Education
About Us
Working with TipRanks
Follow Us
Basilea Pharmaceutica (CH:BSLN)
:BSLN
BSLN Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BSLN Stock 12 Month Forecast
Average Price Target
CHF84.50
▲(75.49% Upside)
| Highest Price TargetCHF100.00 | Average Price TargetCHF84.50 | Lowest Price TargetCHF69.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Kepler Capital
Reiterated
02/18/25
H.C. Wainwright
Reiterated
02/07/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Kepler Capital
Reiterated
02/18/25
H.C. Wainwright
Reiterated
02/07/25
Best Analysts Covering Basilea Pharmaceutica
Which Analyst Should I Follow If I Want to Buy CH:BSLN and Sell After:
1 Month
xxx
Success Rate
5/12 ratings generated profit
Average Return
+0.73%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 41.67% of your transactions generating a profit, with an average return of +0.73% per trade.
3 Months
xxx
Success Rate
4/12 ratings generated profit
Average Return
-1.59%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -1.59% per trade.
1 Year
Success Rate
10/12 ratings generated profit
Average Return
+8.67%
reiterated a buy rating last month
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +8.67% per trade.
2 Years
xxx
Success Rate
12/12 ratings generated profit
Average Return
+16.13%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +16.13% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BSLN Analyst Recommendation Trends
Rating
Sep 24
Oct 24
Dec 24
Jan 25
Feb 25
Strong Buy
5
4
7
6
8
Buy
6
7
4
1
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
11
11
7
8
Each month's total comprises the sum of three months' worth of ratings.
BSLN Financial Forecast
BSLN Stock Forecast FAQ
What is CH:BSLN’s average 12-month price target, according to analysts?
Based on analyst ratings, Basilea Pharmaceutica’s 12-month average price target is CHF84.50.
What is CH:BSLN’s upside potential, based on the analysts’ average price target?
Basilea Pharmaceutica has 75.49% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Basilea Pharmaceutica a Buy, Sell or Hold?
Basilea Pharmaceutica has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Basilea Pharmaceutica’s share price target?
The average share price target for Basilea Pharmaceutica is CHF84.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF100.00 ,and the lowest forecast is CHF69.00. The average share price target represents 75.49% Increase from the current price of CHF48.15.
The highest analyst share price target is CHF100.00 ,and the lowest forecast is CHF69.00. The average share price target represents 75.49% Increase from the current price of CHF48.15.
What do analysts say about Basilea Pharmaceutica?
Basilea Pharmaceutica’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Basilea Pharmaceutica?
To buy shares of CH:BSLN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.